In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn't get the organ to a recipient in time.

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LivaNova announced it received FDA 510(k) clearance for ...

Heart-Lung Machine Market Projected To Hit USD 4.66 Billion By 2035, Owing To Rising Cardiac Surgeries Globally SNS Insider. Increasing Demand for ECMO Systems, Portable Devices, and Pediatric Cardiac ...

Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...

Please provide your email address to receive an email when new articles are posted on . The use of normothermic regional perfusion could injure donor lungs meant for transplantation. More research is ...